Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC02686 |
Type | Targeted Mutation Congenic![]() |
Species | Mus musculus |
Strain name | B6.Cg-Tnxb<tm1Kmat> |
Former Common name | Tnx-/-(F10), TNX-/- F10 |
H-2 Haplotype | |
ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
Background strain | C57BL/6NCrSlc |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Dr. Kenichi Matsumoto, Hokkaido University in 2001. This strain was backcrossed to C57BL/6 over 10 times. |
Strain description | Tnxb, tenascin XB knock-out mice. This strain is useful to study the biological function of extracellular matrix tenascin-X in vivo. TNX-/- F10 line. |
Colony maintenance | Heterozygote x Wild-type [C57BL/6CrSlc] |
References | Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Matsumoto K, Takayama N, Ohnishi J, Ohnishi E, Shirayoshi Y, Nakatsuji N, Ariga H Genes Cells, 6, 1101-1111 (2001). 11737270Triglyceride accumulation and altered composition of triglyceride-associated fatty acids in the skin of tenascin-X-deficient mice. Matsumoto K, Sato T, Oka S, Orba Y, Sawa H, Kabayama K, Inokuchi J, Ariga H Genes Cells, 9, 737 (2004). 15298681Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Matsumoto K, Minamitani T, Orba Y, Sato M, Sawa H, Ariga H Exp. Cell Res., 297, 404 (2004). 15212943 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Tnxb MGI:1932137 | tenascin XB | 17 | Tnxb<tm1Kmat > MGI:3053791 | targeted mutation 1, Ken-ichi Matsumoto | |||
neo | neomycin resistance gene (E. coli) | 17 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E.coli neo, mouse tenascin-X genomic DNA |
Research application | Mouse Models for Human Disease |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Genes Cells, 6, 1101-1111 (2001). The RECIPIENT must contact the DEPOSITOR in the case of application for any publications, patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Ken-ichi Matsumoto (Hokkaido University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |